Predict your next investment

PurpleSun company logo
HEALTHCARE | Medical Facilities & Services
purplesun.com

See what CB Insights has to offer

Founded Year

2011

Stage

Seed VC | Alive

Total Raised

$3M

Last Raised

$3M | 4 yrs ago

About PurpleSun

PurpleSun is a technology company on a mission to transform healthcare by creating the first non-chemical based standard for disinfection.

PurpleSun Headquarter Location

2121 41st Ave Suite 5B

Long Island City, New York, 11101,

United States

Latest PurpleSun News

Coronavirus company news summary – FDA provides EUA for first point-of-care antibody test – PurpleSun introduces disinfection technology

Sep 24, 2020

24 September 2020 (Last Updated September 24th, 2020 09:37) Share Article The US Food and Drug Administration (FDA) has issued Emergency Use Authorisation (EUA) for the first serology point-of-care test for Covid-19. The test, Assure's Covid-19 IgG/IgM Rapid Test Device, previously received authorized for emergency use by certain labs in July to detect those who developed SARS-CoV-2 antibodies, which indicates recent infection. The FDA has now resissued the EUA to approve the test for POC use with the use of fingerstick blood samples. PurpleSun has introduced its PurpleSun E300 system which uses Focused Multivector Ultraviolet (FMUV) light technology to disinfect within 90secs. The PurpleSun E300 can be used to disinfect equipment and rooms as the people inside continue to work around the system safely. PurpleSun has also partnered with Hackensack Meridian Health and Northwell Health to provide government agencies with the decontamination technology. Vela Diagnostics has received the an EUA from the FDA for its ViroKey SARS-CoV-2 RT-PCR Test v2.0. The test is an automated probe-based reverse transcription PCR test that can identify the Covid-19 causing SARS-CoV-2 virus in nasopharyngeal and oropharyngeal swabs. CLIA certified laboratories in the US can use the test to detect Covid-19. CapsoVision has announced that US Food and Drug Administration will provide enforcement discretion to permit the use of CapsoCam Plus small bowel capsule endoscope for patients amid the Covid0-19 pandemic. With this addendum, fully remote capsule endoscopy procedure can be carried out for eligible patients who are monitored at home. This will eliminate the need for in-person interaction which reduces the risk of infection. Related Companies

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing PurpleSun

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned PurpleSun in 1 CB Insights research brief, most recently on Jul 24, 2019.

Expert Collections containing PurpleSun

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

PurpleSun is included in 1 Expert Collection, including Health Monitoring & Diagnostics.

H

Health Monitoring & Diagnostics

2,394 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance

PurpleSun Patents

PurpleSun has filed 8 patents.

The 3 most popular patent topics include:

  • Microbiology
  • Units of length
  • Bacterial diseases
patents chart

Application Date

Grant Date

Title

Related Topics

Status

6/27/2019

1/19/2021

Infectious diseases, Epidemiology, Microbiology, Units of length, Bacterial diseases

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

6/27/2019

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

1/19/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Infectious diseases, Epidemiology, Microbiology, Units of length, Bacterial diseases

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

PurpleSun Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

PurpleSun Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.